B. Lecka-czernik et al., Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPAR gamma 2, J CELL BIOC, 74(3), 1999, pp. 357-371
Cells of the bone marrow stroma can reversibly convert among different phen
otypes. Based on this and on evidence for a reciprocal relationship between
osteoblastogenesis and adipogenesis, we have isolated several murine bone
marrow-derived clonal cell lines with phenotypic characteristics of osteobl
asts or adipocytes, or both. Consistent with a stare of plasticity, cell li
nes with a mixed phenotype synthesized osteoblast markers like type I colla
gen, alkaline phosphatase, osteocalcin, as well as the adipocyte marker lip
oprotein lipase, under basal conditions. In the presence of ascorbic acid a
nd beta-glycerophosphate-agents that promote osteoblast differentiation-the
y formed a mineralized matrix. In the presence of isobutylmethylxanthine, h
ydrocortisone, and indomethacin-agents that promote adipocyte differentiati
on-they accumulated fat droplets, but failed to express adipsin and aP2, ma
rkers of terminally differentiated adipocytes. Furthermore, they were conve
rted back to matrix mineralizing cells when the adipogenic stimuli were rep
laced with the osteoblastogenic ones. A prototypic cell line with mixed phe
notype (UAMS-33) expressed Osf2/ Cbfa 1-a transcription factor required for
osteoblast differentiation, but not PPAR gamma 2-a transcription factor re
quired for terminal adipocyte differentiation. Stable transfection with a P
PAR gamma 2 expression construct and activation with the thiazolidinedione
BRL49653 stimulated aP2 and adipsin synthesis and fat accumulation, and sim
ultaneously suppressed Osf2/Cbfa1, alpha 1 (I) procollagen, and osteocalcin
synthesis. Moreover, it rendered the cells incapable of forming a minerali
zed matrix. These results strongly suggest that PPAR gamma 2 negatively reg
ulates stromal cell plasticity by suppressing Osf2/Cbfa1 and osteoblast-lik
e biosynthetic activity while promoting terminal differentiation to adipocy
tes. (C) 1999 Wiley-Liss, inc.